THYMOSIN ALPHA 1 FOR USE IN TREATMENT OF CYSTIC FIBROSIS
- 专利权人:
- SciClone Pharmaceuticals International Ltd.
- 发明人:
- Luigina ROMANI,Enrico GARACI
- 申请号：
- US16593226
- 公开号：
- US20200023039A1
- 申请日:
- 2019.10.04
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention concerns Thymosin alpha 1 (Tα1) for use in treatment of cystic fibrosis as a CFTR corrector, CFTR potentiator and anti-inflammatory agent.
- 来源网站：
- 中国工程科技知识中心
